Cargando…

Talilmogene Iaherparepvec generates systemic T-cell-mediated anti-tumor immunity

Detalles Bibliográficos
Autores principales:	Piasecki, Julia, Tiep, Le, Zhou, Jean, Beers, Courtney
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991094/ http://dx.doi.org/10.1186/2051-1426-1-S1-P198

Ejemplares similares

The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice
por: Mangsbo, Sara M, et al.
Publicado: (2014)

Generation and utilization of polyfunctional anti-tumor CD4+ T cells
por: Zhou, Gang, et al.
Publicado: (2015)

Blocking indolamine 2,3 dioxygenase mediated rebound immune suppression improves systemic anti-tumor effects of radio-immunotherapy
por: Monjazeb, Arta M, et al.
Publicado: (2015)

Bortezomib enhances anti-tumor T cell immunity by remodeling Notch system
por: Thounaojam, Menaka, et al.
Publicado: (2014)

Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy
por: Albershardt, Tina C, et al.
Publicado: (2015)

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
por: Yopp, Adam, et al.
Publicado: (2014)

The impact of metabolic stress on anti-tumor immunity in laboratory mice
por: Kokolus, Kathleen M, et al.
Publicado: (2013)

Adenosine regulates radiation therapy-induced anti-tumor immunity
por: Wennerberg, Erik, et al.
Publicado: (2015)

The impact of β-adrenergic signaling on radioresistance and anti-tumor immunity
por: Bucsek, Mark, et al.
Publicado: (2015)

Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice
por: Johnson, Christopher B, et al.
Publicado: (2014)

Mcl-1 expression influcences CD8+ anti-tumor immunity.
por: Pfannenstiel, Lukas W, et al.
Publicado: (2015)

Intratumoral IL-15 potentiates radiation-induced anti-tumor immunity
por: Pilones, Karsten, et al.
Publicado: (2015)

Effects on tumor immunity of anti-TGF-beta with different isoform specificities
por: Terabe, Masaki, et al.
Publicado: (2014)

Core skin DC signatures control immune tolerance to skin cancer and limit anti-tumor immunity
por: Nirschl, Christopher, et al.
Publicado: (2015)

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients
por: Trivedi, Sumita, et al.
Publicado: (2015)

Detection of antibody therapy-induced anti-tumor immune responses using anti-CD8 immuno-pet
por: Tavare, Richard, et al.
Publicado: (2015)

Enhancing anti-tumor immunity through local gene delivery to lymph nodes
por: Dold, Neil M, et al.
Publicado: (2015)

Programming the lymph node microenvironment to enhance anti-tumor T cell immunity in neuroblastoma
por: Gammon, Joshua M, et al.
Publicado: (2015)

Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells
por: Kwilas, Anna R, et al.
Publicado: (2014)

Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models
por: Spahn, Jessica, et al.
Publicado: (2015)

Modification of BTLA signaling motifs in TIL exhibits positive signals that mediate anti-tumor control
por: Ritthipichai, Krit, et al.
Publicado: (2015)

Immune system activation through immunogenic cell death and tumor recruitment of dendritic cells is required for anti-tumor activity of a plant-derived polyphenol rich fraction
por: Gomez-Cadena, Alejandra, et al.
Publicado: (2015)

Adjuvant inhibition of iAPC function in the tumor microenvironment promotes therapeutic immunity in the setting of vaccination-induced T cell anti-tumor response
por: Antonios, Joseph, et al.
Publicado: (2015)

Innate and adaptive immunity contribute to the anti-tumor mechanisms of action of OncoVEX(mGM-CSF)
por: Cooke, Keegan, et al.
Publicado: (2015)

Modulation of immune cell infiltrate with sunitinib to improve anti-PD1 therapy in preclinical tumor model
por: Rayman, Patricia, et al.
Publicado: (2015)

STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment
por: Ohkuri, Takayuki, et al.
Publicado: (2014)

Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity
por: Mao, Yumeng, et al.
Publicado: (2014)

Dopamine mediates vagal modulation of the immune system by electroacupuncture
por: Rosas, R Torres, et al.
Publicado: (2014)

The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent
por: He, Li-Zhen, et al.
Publicado: (2015)

Myeloid cell biology and inhibition of anti-tumor immune responses by MPDL3280A in urothelial bladder cancer
por: Xiao, Yuanyuan, et al.
Publicado: (2014)

Anti-tumor effects of anti-PD-L1 therapy in an orthotopic bladder tumor model
por: Lyon, Amanda, et al.
Publicado: (2014)

IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
por: Marsal, S, et al.
Publicado: (2010)

Discovering genetic profiles by array-CGH in familial breast tumors
por: Nederlof, PM, et al.
Publicado: (2005)

Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
por: Patel, Mira, et al.
Publicado: (2015)

The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
por: Sansal-Castellano, Isabelle, et al.
Publicado: (2015)

Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells
por: Lepone, Lauren, et al.
Publicado: (2015)

P03-02. SCID-hu mice generate HIV specific human immune responses after gp96 vaccination
por: Gonzalez, LE, et al.
Publicado: (2009)

Anti-tumor characteristics of radiation-induced tumor-infiltrating neutrophils
por: Takeshima, Tsuguhide, et al.
Publicado: (2014)

Anti-endotoxin immunity in abdominal sepsis patients
por: Butyrsky, O, et al.
Publicado: (2011)

Image guided cryoablation of cancer with intra-tumoral injection of anti-CTLA-4 and PD-1 immune check-point inhibitors
por: Rosenberg, Mark A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_69dkiani8b0mifugeontni18qv